IL6 and Cirrhosis: Our study provides intriguing evidence that continuous noninvasive monitoring of inflammatory biomarkers may predict outcomes – as patients with cirrhosis had higher evening and nocturnal levels of sweat CRP and IL6 when compared with healthy controls.